Neurology Semmelweis ❲COMPLETE❳
Today, the university provides a comprehensive spectrum of neurological patient care, which has been significantly expanded and integrated in recent years. A landmark change occurred in March 2024, when Semmelweis University expanded its patient-care profile to officially include adult neurosurgery and neurointerventional stroke care. This was achieved through the integration of neurology, neurointervention, and neurosurgical services at the National Institute of Mental Health, Neurology, and Neurosurgery (OMIII), creating a powerful, multidisciplinary environment for treating complex neurological conditions.
Research at Semmelweis University is characterized by its diversity, translational approach, and focus on unmet medical needs. The university is home to the , a premier institution that has been training the next generation of researchers since 2000. Active clinical trials focus on critical areas such as acute ischemic stroke and major depressive disorder, with studies often investigating novel therapies for patients who have not responded to standard treatments.
Disclaimer: This article is based on information available as of May 2026 and highlights the general, publicly available activities of the institution.
In the late 19th and early 20th centuries, neurologists such as Louis Pasteur, Robert Koch, and Jean-Martin Charcot built on Semmelweis's discoveries to develop new treatments and understandings of neurological disorders. The discovery of the role of bacteria in causing diseases such as meningitis, encephalitis, and neurosyphilis revolutionized the field of neurology. neurology semmelweis
Stroke care is a cornerstone of the department's clinical and academic output. Semmelweis University has been at the forefront of evaluating modern protocols to maximize the efficiency of acute interventions:
Semmelweis University is a leader in studying the early markers of dementia and movement disorders.
Neurology at Semmelweis also identifies specific electrophysiological "features" during deep sleep: Today, the university provides a comprehensive spectrum of
: Semmelweis is a regional leader in applying Deep Brain Stimulation (DBS) to treat Parkinson’s disease, significantly improving motor function and quality of life for patients.
A major research focus is on healthy brain aging. The group investigates two critical factors in maintaining mental and physical health in older adults: preserving cognitive abilities and achieving a pain-free existence. Their work involves identifying new therapeutic targets and developing predictive cognitive test systems for neurodegenerative diseases. A notable project is the Hungarian Longitudinal Study of Healthy Brain Aging (HuBA) , which explores brain aging using advanced biomarkers like retinal microvascular imaging, dual-task gait analysis, and functional MRI.
: Researchers have identified alterations in the visuospatial system —specifically reduced cortical thickness in temporal areas—as non-invasive biomarkers for early cognitive decline. Research at Semmelweis University is characterized by its
Comprehensive training in neurology for medical students in Hungarian, English, and German.
The Department of Neurology at Semmelweis University is a comprehensive clinical, academic, and research center. It operates as both a primary care facility for local regional populations and a tertiary referral center for highly complex neurological cases across Hungary.
